ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.98
+0.02 (+2.42%)
As of Jun 30, 10:42 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,030.1% upside
Low Target $6.75
Average Target $11.07
High Target $12.78
Current Price $0.98
Current
$0.98
Target
$11.07
$6.75 $11.07 avg $12.78
Scenario Analysis
Bear Case
$6.75
589.1%
Low target
Base Case
$11.07
+1,030.1%
Avg target
Bull Case
$12.78
+1,204.6%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.64
-62.9% from high
52-Week Low
$0.50
+95.9% from low
Target vs 52W High
$11.07
+319.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%